BD Rx Inc., a wholly-owned subsidiary of Becton, Dickinson and Co., has received its third approval from the FDA for a drug to be offered in its new BD Simplist line of ready-to-administer prefilled generic injectables. The antiemetic Ondansetron Injection, USP 4mg/2mL (2mg/mL) is used to prevent postoperative nausea and vomiting, and is currently on the FDA drug shortage list due to demand increases and supply issues for other manufacturers.   “We’re proud to be expanding our BD Simplist produc...